- Home
- WOOF vs ATRC Comparison
WOOF vs ATRC Comparison
Compare WOOF & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOOF
- ATRC
- Stock Information
- Founded
- WOOF 1965
- ATRC 2000
- Country
- WOOF United States
- ATRC United States
- Employees
- WOOF N/A
- ATRC N/A
- Industry
- WOOF Other Specialty Stores
- ATRC Medical/Dental Instruments
- Sector
- WOOF Consumer Discretionary
- ATRC Health Care
- Exchange
- WOOF Nasdaq
- ATRC Nasdaq
- Market Cap
- WOOF 937.4M
- ATRC 1.7B
- IPO Year
- WOOF 2021
- ATRC 2005
- Fundamental
- Price
- WOOF $3.47
- ATRC $35.01
- Analyst Decision
- WOOF Hold
- ATRC Strong Buy
- Analyst Count
- WOOF 11
- ATRC 10
- Target Price
- WOOF $3.91
- ATRC $49.60
- AVG Volume (30 Days)
- WOOF 4.7M
- ATRC 411.9K
- Earning Date
- WOOF 08-28-2025
- ATRC 10-28-2025
- Dividend Yield
- WOOF N/A
- ATRC N/A
- EPS Growth
- WOOF N/A
- ATRC N/A
- EPS
- WOOF N/A
- ATRC N/A
- Revenue
- WOOF $6,045,495,000.00
- ATRC $499,946,000.00
- Revenue This Year
- WOOF $0.03
- ATRC $16.32
- Revenue Next Year
- WOOF $1.36
- ATRC $12.37
- P/E Ratio
- WOOF N/A
- ATRC N/A
- Revenue Growth
- WOOF N/A
- ATRC 16.28
- 52 Week Low
- WOOF $2.28
- ATRC $25.57
- 52 Week High
- WOOF $6.29
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- WOOF 50.43
- ATRC 47.47
- Support Level
- WOOF $3.57
- ATRC $34.21
- Resistance Level
- WOOF $3.70
- ATRC $38.08
- Average True Range (ATR)
- WOOF 0.23
- ATRC 1.55
- MACD
- WOOF -0.02
- ATRC -0.25
- Stochastic Oscillator
- WOOF 33.33
- ATRC 20.67
About WOOF Petco Health and Wellness Company Inc.
Petco Health and Wellness Co Inc is a pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners with pet care centers in approximately 50 states, the District of Columbia and Puerto Rico. The Company also offers an expanded range of consumables, supplies, and services through its website and mobile app.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.